Paasa Logo
Whan In Pharm Co.,Ltd. logo
016580KRXMarket closedOpens 9:00am KST

Whan In Pharm Co.,Ltd.

₩10,180.00Last updated
+₩0.00 (0.00%)Past day
Timezone

Whan In Pharm Co.,Ltd. (KRX: 016580) is trading at ₩10,180.00, about ₹735 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET. Whan In Pharm is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.

Quote

Open:₩10,100.00
Previous close:₩10,180.00
Volume:14.79K

Today's low

₩10,080.00

Today's high

₩10,190.00

52 week low

₩9,160.00

52 week high

₩12,140.00

016580 opened at ₩10,100.00, closed previously at ₩10,180.00, and has traded between ₩9,160.00 and ₩12,140.00 over the past 52 weeks.

About

Whan In Pharm Co.,Ltd. is a South Korean pharmaceutical enterprise specializing in the research, development, manufacturing, promotion, and distribution of therapeutic products. Their comprehensive portfolio encompasses treatments for mental health conditions (such as antidepressants and antipsychotics), neurological disorders (including nootropics, anti-dementia, and anti-epileptics), cardiovascular and gastrointestinal ailments, infectious diseases, allergies, pain and inflammation, metabolic imbalances, respiratory issues, and a variety of other central nervous system applications. Established in 1978, the company's corporate headquarters are situated in Seoul, South Korea.

Country
KR
CEO
Wonbum Lee
Exchange listed on
KRX
Industry
Drug Manufacturers - Specialty & Generic
Base currency
KRW
Full Time Employees
671
Sector
Healthcare
IPO date
04/01/2000

Key statistics

Avg. volume

39.68K

Market cap

₩188.17B

P/E Ratio

9.00

Price-to-sales ratio

0.69

Enterprise value

₩147.65B

Free cash flow yield

2.94%

Debt-to-equity ratio

0.00

Return on equity

3.23%

ROIC

2.78%

Beta

0.20

Dividend yield

2.95%

Last dividend

₩300.00

Financial overview

Revenue

₩255.21B

Earnings per share

₩857.00

Free cash flow

₩6.19B

Net profit margin

7.48%

Gross margin

45.78%

EBITDA

₩24.07B

Revenue growth

-1.69%

Similar securities

This is not an investment recommendation

Whan In Pharm for Indian investors

Whan In Pharm is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.

Taxes on Whan In Pharm for Indian residents

Trading and limits

Trading hours
9:00 am – 3:30 pm KST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Whan In Pharm’s current yield is 2.95%.Dividend tax explained

FAQs

Can I buy Whan In Pharm on Paasa?

Whan In Pharm (016580) has been listed on the Korea Exchange since 2000, in the Drug Manufacturers - Specialty & Generic industry. Whan In Pharm is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.

How much does one Whan In Pharm share cost in rupees?

One Whan In Pharm share is ₩10,180.00 — about ₹735 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Whan In Pharm price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for investing abroad from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.

How are gains on Whan In Pharm shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Whan In Pharm price.

Does Whan In Pharm pay a dividend, and how is it taxed in India?

Yes. Whan In Pharm pays a dividend and the current yield is 2.95%; the last declared dividend was ₩300.00 per share, about ₹21.65. Dividends are taxed at your slab rate in India.

When does KRX trade, in Indian time?

The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.

Do I have to declare Whan In Pharm shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.

Does the rupee rate affect what I make on Whan In Pharm?

Yes. Whan In Pharm is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.